What is Shanghai Haohai Biological Technology Co Pre-Tax Income?
Pretax income is the income that a company earns before paying income taxes. Shanghai Haohai Biological Technology Co's pretax income for the
three
months ended in Dec. 2024 was HK$85 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was HK$505 Mil.
Shanghai Haohai Biological Technology Co's pretax margin was 13.18%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Shanghai Haohai Biological Technology Co Pre-Tax Income Chart
Shanghai Haohai Biological Technology Co Annual Data
Competitive Comparison of Shanghai Haohai Biological Technology Co's Pre-Tax Income
For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Haohai Biological Technology Co's Pre-Tax Income Distribution in the Biotechnology Industry
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$505 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Haohai Biological Technology Co (HKSE:06826) Pre-Tax Income Explanation
Shanghai Haohai Biological Technology Co's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as
During the past 11 years, Shanghai Haohai Biological Technology Co's highest Pretax Margin was 48.30%. The lowest was 11.21%. And the median was 24.54%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Haohai Biological Technology Co Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Shanghai Haohai Biological Technology Co Business Description
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to single operating segment which is the manufacture and sale of biologicals, medical hyaluronate and intraocular lens, research and development of biological engineering and pharmaceutical products and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06826 has been successfully added to your 